Experts
Stories by Tim Boreham
Tech
CRITERION: 3 tasty stocks the tech recovery forgot
Health & Biotech
Dr Boreham’s Crucible: Is serial shopper Trajan Group a buy?
News
CRITERION: It’s a small cap smorgasboard with takeover targets on the table
Experts
CRITERION: Credit where it’s due – these ASX collectors are knocking on the door
Health & Biotech
Dr Boreham’s Crucible: Will the FDA bend the knee after Paradigm’s Phase III tests?
Experts
CRITERION: Taking a punt on gambling stocks? It’s not as black and red as it used to be
News
CRITERION: Fear a falling market? Maybe an ‘anti-market’ ETF is the hedge you’re looking for
Health & Biotech
Dr Boreham’s Crucible: With sales success, does LBT have the world on a plate?
News
CRITERION: Investing in aged care – it never gets old
Health & Biotech
Dr Boreham’s Crucible: Will AstraZeneca cash put Starpharma on a rocket back to all-time highs?
News